Both Sp1 and Smad participate in mediating TGF-β1-induced HGF receptor expression in renal epithelial cells
- 1 January 2005
- journal article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 288 (1) , F16-F26
- https://doi.org/10.1152/ajprenal.00318.2003
Abstract
Hepatocyte growth factor (HGF) receptor is a transmembrane receptor tyrosine kinase encoded by the c-met protooncogene. In this study, we demonstrated that c-met expression was upregulated in the kidney after obstructive injury in mice. Because the pattern of c-met induction was closely correlated with transforming growth factor-β1 (TGF-β1) expression in vivo, we further investigated the regulation of c-met expression in renal tubular epithelial (HKC) cells by TGF-β1 in vitro. Real-time RT-PCR and Northern and Western blot analyses revealed that TGF-β1 significantly induced c-met expression in HKC cells, which primarily took place at the gene transcriptional level. Overexpression of inhibitory Smad7 completely abolished c-met induction, indicating its dependence on Smad signaling. Interestingly, TGF-β1-induced c-met expression was also contingent on a functional Sp1, as ablation of Sp1 binding with mithramycin A abrogated c-met induction in HKC cells. Transfection and sequence analysis identified a cis-acting TGF-β1-responsive region in the c-met promoter, in which resided a putative Smad-binding element (SBE) and an adjacent Sp1 site. TGF-β1 not only induced Smad binding to the SBE/Sp1 sites in the c-met promoter, but also enhanced the binding of Sp proteins. Furthermore, Sp1 could form a complex with Smads in a TGF-β1-dependent fashion. These results suggest a novel regulatory mechanism controlling c-met expression by TGF-β1 in renal epithelial cells, in which both Smad and Sp proteins participate and cooperate in activating c-met gene transcription.Keywords
This publication has 51 references indexed in Scilit:
- Role of TGF-β1 in Experimental GlomerulonephritisPublished by Wiley ,2007
- Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of actionAmerican Journal of Physiology-Renal Physiology, 2004
- Hepatocyte growth factor counteracts transforming growth factor‐β1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized miceThe FASEB Journal, 2002
- Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathyKidney International, 2002
- Coupling Met to Specific Pathways Results in Distinct Developmental OutcomesMolecular Cell, 2001
- Sp1 and Smad Proteins Cooperate to Mediate Transforming Growth Factor-β1-induced α2(I) Collagen Expression in Human Glomerular Mesangial CellsPublished by Elsevier ,2001
- Efficient TGF-β Induction of the Smad7 Gene Requires Cooperation between AP-1, Sp1, and Smad Proteins on the Mouse Smad7 PromoterJournal of Biological Chemistry, 2000
- Plasminogen-Related Growth Factor and Semaphorin Receptors: A Gene Superfamily Controlling Invasive GrowthExperimental Cell Research, 1999
- Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: Its specific receptor c-met does.Hepatology, 1996
- Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene ProductScience, 1991